ABSTRACT Pulsatile cardiopulmonary bypass has been shown to preserve renal function and could therefore have considerable clinical value in patients undergoing cardiac surgery with preoperative renal insufficiency, by protecting them from further postoperative renal deterioration. Our three-year experience with pulsatile bypass in 29 patients with a preoperative serum creatinine concentration over 1-7 mg/100 ml (mean 2-9, range 1-8-6-1 mg/100 ml) (>150 ,mol/l Since November 1978, all patients undergoing cardiac surgery with a preoperative serum creatinine concentration repeatedly greater than 1-7 mg/100 ml (normal 0-8-1*2 + SD 0-2 mg/100 ml) (150 ,umol/l (normal 71-106 + SD 18,molI1)) have been selected for pulsatile perfusion. Twenty-nine patients, four women and 25 men, ranging in age from 25 to 78 years (mean 60 years) underwent cardiac operations for disabling symptoms. The mean preoperative creatinine concentration was 2-9 ± 1-2 mg/100 ml (median 2*3, range 1-8-6-1) (256 + 106 ,tmol/l (median 203, range 
(mean 256, range 159-539 4molI1)) supports this premise. There were no renal deaths in the perioperative period and only two patients had irreversible postoperative deterioration in renal function; one died on day 3 of low-output syndrome and the other had rapidly progressive nephrosclerosis and died of that disease one year later. Postoperative oliguria occurred in the patient with low cardiac output and in only one other. This experience contrasts with our previous experience and that reported by others with non-pulsatile bypass in patients with renal insufficiency. We suggest that pulsatile bypass should be considered for cardiac surgery in patients with preoperative renal dysfunction.
Although the use of pulsatile cardiopulmonary bypass is increasing, many of its alleged benefits are unproved clinically and remain controversial. '13 Nevertheless, the kidney appears to respond favourably to pulsatile as opposed to non-pulsatile blood flow. Both in vitro and in vivo studies have shown that pulsation maintains renal perfusion and oxidative metabolism,4-7 augments urine flow,8-'0 and mitigates stress responses in vasopressin and in the renin-angiotensin system that have been observed to occur with depulsation." '-16 We reasoned that in patients with preoperative renal insufficiency who have reduced functional renal reserve, pulsatile bypass might offer the clinical advantage of preserving functioning nephron mass and in so doing might prevent postoperative oligura, uraemia, and-in the worst cases-the need for temporary or even permanent dialysis. We are unaware of any reports of pulsatile cardiopulmonary bypass in patients with pre-existing renal insufficiency and therefore present our three-year experience at the Medical College of Wisconsin with pulsatile cardiopulmonary bypass in such patients.
Patients and methods
Since November 1978, all patients undergoing cardiac surgery with a preoperative serum creatinine concentration repeatedly greater than 1-7 mg/100 ml (normal 0-8-1*2 + SD 0-2 mg/100 ml) (150 ,umol/l (normal 71-106 + SD 18,molI1)) have been selected for pulsatile perfusion. Twenty-nine patients, four women and 25 men, ranging in age from 25 The patients as a group showed no appreciable overall postoperative deterioration in renal function. Notable exceptions are discussed below. Urine output during cardiopulmonary bypass was acceptable (-1 mlmin) or brisk in virtually all patients. The mean urine output was 460 + 430 ml (range 60-2000 ml), or 3-8 + 3-8 ml/min. The mean urine output during anaesthesia was 1150 + 670 ml and for the subsequent three 24-hour periods 1900 + 800, 1600 + 700, and 1500 + 700 ml. Only two patients (Nos 1 and 2-see below) were oliguric during the first 72 postoperative hours and one of these (No 2) was also oliguric during operation (urine output < 1 ml/min).
The postoperative blood urea and serum creatinine concentrations are summarised in table 4 for the entire group and certain subgroups. While there are no statistically significant alterations in these indices of renal function within the total series and subgroups-or between subgroups, certain trends figure 1 . Patients with acute renal insufficiency of renal aetiology (alone or in combination) also tended to improve during the first three postoperative days. Trend lines for serum creatinine concentrations in these patients are seen in figure 2 . Improvement was most striking in patient 4, who was being haemodialysed before operation for isolated immune-complex nephritis. Again patient 3, with combined prerenal and renal factors, skewed the group data. On the other hand, patients with chronic renal insufficiency appeared far more vulnerable to insult by operation and to postoperative deterioration in function. Trend lines for all 29 patients are seen in figure 3 . Of the seven patients who showed apparent deterioration in function from the preoperative state to day 3, as defined by a rise in serum creatinine concentration of > 1 mg/dl (88 gmoIl) ( immune-complex nephritis with a preoperative low cardiac output (1-3 1/min/m2), and patient 2, who had generalised arteriosclerotic vascular disease and hypertensive nephrosclerosis, both had postoperative exacerbation of renal insufficiency. They were two of six patients in the series who had cardiac catheterisation with angiography within 24 uneventfully, but despite excellent perfusion values she manifested further non-oliguric renal failure, which did not reverse and led to her death one year later. She was the only survivor to show permanent postoperative deterioration of renal function.
Patient 8 had a transient non-oliguric rise in serum creatinine after an uneventful coronary artery bypass. This deterioration was not readily explained by any factor mentioned previously, although it is of interest that he was one of only two patients who did not receive frusemide at initiation of bypass.
Discussion
The pathogenesis of renal failure in patients undergoing non-pulsatile cardiopulmonary bypass has not been fully explained, although decreased renal perfusion with increased vascular resistance appear to be primary aetiological factors.'62' 22 With diminution in renal cortical blood flow and in sodium reabmmmmmoni 547 .
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group.bmj.com on June 23, 2017 -Published by http://thorax.bmj.com/ Downloaded from sorption in the proximal tubule, the macula densa of the juxtaglomerular apparatus increases renin secretion. Production of angiotensin ensues, followed by preglomerular arteriolar constriction and an associated further fall in glomerular filtration. Vascular resistance within the kidney rises and blood flow is shifted from cortex to medulla. The potential value of pulsation in preventing this sequence of events has been suggested by several studies,4-6 the overall results of which imply that the addition of pulsation to standard cardiopulmonary bypass might help to maintain normal intrarenal haemodynamics and nephron perfusion and mitigate the potential for the postulated sequence of events that leads to renal failure.
The results in this series of 29 patients with moderate-to-severe preoperative renal insufficiency support this premise. Only two patients had irreversible postoperative deterioration in renal function. One suffered irremediable low output syndrome with its expected consequences. The other had an unusually active nephrosclerotic process, from which she died one year later. Her renal failure while she was in hospital was nevertheless nonoliguric and did not prevent successful convalescence from her mitral valve replacement. Each of the other 27 patients showed postoperative preservation of preoperative nephron mass and function. In 22 cases postoperative serum creatinine concentrations were stable or improved, while five patients had a considerable rise in postoperative serum creatinine concentration but subsequently returned to preoperative levels or below. When renal function did worsen after operation, it was mostly in patients with chronic renal disease-a logical sequel to insult to a fixed, limited nephron mass incapable of the recovery expected with prerenal azotaemia or acute glomerular or tubular injury.
The protective effects of pulsatile bypass are likely to have been lessened in two of the six patients who received angiographic contrast shortly before operation (patients 2 and 3). Whenever possible the patient with underlying renal disease should be allowed a period of a least 24 and preferably 72 hours after contrast injection for clearance of contrast and for equilibration of renal function. An elective operation should be postponed to allow recovery from further tubular dysfunction.
Because of the very precarious clinical condition of patients with limited renal reserve, we believe they should be offered the potential benefit of other supportive measures besides pulsatile bypass. Frusemide to enhance renal cortical blood flow is one such adjunct. Another is dopamine, which, while not given to any patient during operation, was used effectively in low dose afterwards in one patient to improve urine output. There may be a role for intraoperative low-dose dopamine to supplement pulsatile bypass in patients with renal insufficiency. We have no experience with this technique and would use it reluctantly whenever the increase in cardiac contractile state and oxygen demand might impair myocardial protection.
The possible morbidity associated with pulsatile bypass with an in-line pulsator must be weighed against its intended benefits. Cerebrovascular damage is clearly the major hazard. There were three such episodes in this series, a rate of 10%. Two The evidence for the efficacy of pulsatile bypass in this series is circumstantial. We are nevertheless convinced of its benefit because experience with the patients reported in this paper contrasts strikingly with our own previous anecdotal experience with similar patients on whom it was not used. Furthermore, the systematically analysed and frequently cited reports of Abel et al, 25 Porter et al, 26 Yeboah et al,27 and Bhat et al,28 each of which examined the incidence and causes of renal failure after cardiac surgery performed with pulseless perfusion, showed unequivocally that preoperative renal insufficiency carried with it an excessive postoperative incidence of renal morbidity and mortality that was proportional to the degree of renal insufficiency present at the time of operation. Typifying these findings was Abel et al's worst subgroup of 18 patients with a mean preoperative creatinine concentration of 2-03 mg/dl (179-5 ,umol/l), compared with our mean of 2-9 mg/dl (256 ,mol/1). Postoperative creatinine levels in all patients rose to 5 mg/dl (442 ,umoVl), 15 patients required dialysis, and mortality was 88*8%. Of additional significance in these reports was that the duration of non-pulsatile cardiopulmonary bypass contributed independently and directly to the incidence of postoperative renal failure. The duration of bypass in our series, a mean of 135 minutes, bore no relation to postoperative renal function.
Our own practice now is to use pulsatile bypass in all patients with preoperative renal insufficiency, a policy that seems physiologically sound and worthy of consideration and further evaluation by others. We realise that the credibility of our data on the value of pulsation rests on uncontrolled comparison with other series and on the personal experience of surgeons who, like us, have been dissatisfied with the use of non-pulsatile flow in the presence of established renal insufficiency. Controlled studies of pulsatile versus non-pulsatile perfusion in patients with poor renal function are clearly required, though they may be difficult to perform in view of the many perioperative variables which may influence renal function. 
